GLPG0634 25mg
GLPG0634 is an orally-available, selective inhibitor of JAK1 (Janus kinase 1) being developed by Galapagos for the treatment of rheumatoid arthritis and potentially other inflammatory diseases.
Trivial name | GLPG0634 25mg |
Catalog Number | A13162-25 |
Alternative Name(s) | N/A |
Molecular Formula | C23H18N6O2 |
CAS# | 1206101-20-3 |
SMILES | c1cc(n2c(c1)nc(n2)NC(=O)C3CC3)c4ccc(cc4)OCc5ccc(nc5)C#N |
Size | 25mg |
Supplier Page | http://www.adooq.com/glpg0634.html |